Immune changes in HIV-1 infection: Significant correlations and differences in serum markers and lymphoid phenotypic antigens

Clinical Immunology and Immunopathology

Volumn 64, Issue 1, 1992, Pages 63-70

  Bass, Hong Z ^a   Nishanian, Parunag ^a   Hardy, W David ^a   Mitsuyasu, Ronald T ^a   Esmail, Emu ^a   Cumberland, William ^b   Fahey, John L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CD45 ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR; LYMPHOCYTE ANTIGEN; NEOPTERIN;

ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOREGULATION; LYMPHOCYTE ACTIVATION; PHENOTYPE; PRIORITY JOURNAL; SERODIAGNOSIS;

ANTIGENS, CD; ANTIGENS, CD20; ANTIGENS, CD45; ANTIGENS, CD57; ANTIGENS, DIFFERENTIATION; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BETA 2-MICROGLOBULIN; BIOPTERIN; CD4-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS; HIV INFECTIONS; HLA-DR ANTIGENS; LYMPHOCYTE SUBSETS; MACROPHAGE-1 ANTIGEN; NEOPTERIN; RECEPTORS, INTERLEUKIN-2; SOLUBILITY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026755620     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1016/0090-1229(92)90060-2     Document Type: Article

References (36)

1. AIDS pathogenesis: A dynamic interaction between HIV-1 and the immune system
2. Four-year prospective study of homosexual men: Correlation of immunologic abnormalities, clinical status, and serology to human immunodeficiency virus
3. Serum neopterin changes in HIV-1-infected subjects: indicator of significant pathology, CD4 T cell changes, and the development of AIDS
4. Serum β2M-microglobulin level increases in HIV-1 infection: Relation to seroconversion, CD4 T cell fall and prognosis
5. The prognosis value of cellular and serologic markers in infection with human immunodeficiency virus type 1
6. + lymphocytes
7. In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLAV-III/LAV)
8. HIV-1 persistence in monocytes leads to pathogenesis and AIDS
9. The effect of immunomodulators on PHA or γ-IFN induced release of neopterin from purified macrophages and peripheral blood mononuclear cells
10. Selective induction of mononuclear phagocytes to produce neopterin by interferons
11. Neopterin as a marker for activated cell-mediated immunity: Application in HIV-1 infection
12. Serum increases and lymphoid cell surface losses of IL-2 receptor CD25 in HIV-1 infection: Distinctive parameters of HIV-1-induced changes
13. Soluble IL2 receptor levels in serum from blood donors seropositive for HIV-1
14. A secreted form of the human lymphocyte cell surface molecule CD8 arises from the alternative splicing
15. Serum soluble CD8 molecule is a marker of CD8 T cell activation in HIV-1 disease
16. Seropositively for HIV-1 and the development of AIDS or AIDS related condition: Three-year follow-up of the San Francisco General Hospital Cohort
17. Soluble interleukin 2 receptors are elevated in patients with AIDS or at risk of developing AIDS
18. Soluble IL2 receptors in AIDS. Correlation of its serum level with classification of HIV-1-induced diseases and its characterization
19. The effect of zidovudine treatment on serum neopterin and β2-microglobulin levels in mildly symptomatic, human immunodeficiency virus type-1 (HIV-1-1) seropositive individuals
20. Surrogate markers for survival in patients with AIDS and AIDS-related complex treated with zidovudine
21. Selective alterations in immunoregulatory lymphocyte subsets in early HIV-1 (human T lymphotropic virus type III/lymphadenopathy-associated virus) infection
22. T-cell subset alterations in HIV-1-infected homosexual men: NIAID multicenter AIDS cohort study
23. Infection with human immunodeficiency virus is associated with an in vivo increase in B lymphocyte activation and immaturity
24. Interrelationships between serologic markers of immune activation and T lymphocyte subsets in HIV-1 infection
25. The safety and efficacy of zidovudine in the treatment of subjects with mildly symptomatic human immunodeficiency virus type I infection
26. Zidovudine in asymptomatic human immunodeficiency virus infection
27. Cell dysfunction and depletion in AIDS: The programed cell death hypothesis
28. Cytokine regulation of HIV-1 expression
29. Tumor necrosis factor and interferon as prognostic markers in human immunodeficiency virus (HIV-1) infection
30. Isolation of a cDNA encoding the human CD38 (T10) molecule, a cell surface glycoproterin with an unusual discontinuous pattern of expression during lymphocyte differentiation
31. Human naive and memory T cells
32. Loss of CD45RA and gain of UCHL-1 reactivity is a feature of primed T cells
33. Leu 8/TQ1 is the human equivalent of the Mel-14 lymph node homing receptor
34. Alterations in cytotoxic and phenotypic subsets of natural killer cells in acquired immune deficiency syndrome (AIDS)
35. Morphologic and phenotypic features of the subpopulations of Leu2+ cells that suppresses B cell differentiation
36. Correlation of the percentage of activated CD3+DR+ lymphocytes to serum neopterin level in HIV-1-seropositive haemophiliacs